The Concussion Specialists™ (TBI3)

Phone:  (833)363 8243 (TBi3)

Email: contact@tbi3.com

Unique Position

| Proprietary Tech Proprietary Tech + Proprietary Reportingv

OUR UNIQUE POSITION

The TBI3™ Digital Health Platform (3DHP) utilizes quantitative and qualitative inputs referenced by years of peer reviewed clinical
research studies. Data and results are reviewed and assessed by a Board Certified and trained Neurologist. Reports and
cohesive assessments are provided to our clients within 48 hours of a patient visit.

Proprietary Tech:

Through a combination of several technologies and algorithms, TBI3™ creates a comprehensive report that is objective in its findings. To replicate a TBI3™ result, a patient would generally spend 10 to 12 hours to visit a neurologist and perform follow-up diagnostic testing. A trained technician can complete a TBI3™ diagnostics test in under 40 minutes.

Proprietary Reporting:

  • FDA cleared and clinically proven
  • Scientifically quantifies the present AND future impacts of TBI
  • If a TBI or mTBI is present, reports will quantify injury permanence
tbi3
tbi3
BrainScope® One (3YR Exclusivity Contract)

OUR TECHNOLOGY

Revolutionizing Head Injury and Concussion Assessment
BrainScope® One (3YR Exclusivity Contract) Combining state-of-the-art handheld technology with a user-friendly disposable headset, while leveraging advanced algorithms and machine learning technologies, the BrainScope® One system identifies and evaluates physiological biomarkers of brain injury.

The system is engineered for fast, confident decision-making— even in challenging settings—integrating easily in acute assessment without impinging on the patient care path. The only FDA-approved algorithm to help assess concussion and Traumatic Brain

3-Step Process

1

Step: 1

EEG Measurement: 5 min prep, 5 min for test
2

Step: 2

Cognitive Performance Tests: 8 min
3

Step: 3

Digitized Concussion Assessments: Variable by Selected Assessment

The BrainScope® One system provides four primary capabilities,
which can be configured to meet users’ needs:

RightEye® (3-YR Exclusive)

OUR TECHNOLOGY

A Portable Window on Concussion

On the sidelines or in the clinic, RightEye device is a fully-integrated, eye-tracking device for rapid, reliable assessment of visual attention – the most common deficit after a force to the head

Fast: The testing sequence takes 30 seconds and the entire administration and output of score occurs within two minutes.

Accurate: The RIghtEye device has great test re-test reliability, far exceeding conventional neuro-cognitive tests. In addition, effort and learning effects, which complicate neuro-cognitive testing are not issues for the RightEye technology.

Ultra-Portable: The RightEye comes in a customized rugged briefcase that weighs less than five pounds and is small enough to use an airplane carry-on, so you can perform testing anywhere, anytime.

Validated: Our clinical data on eye tracking impairments in concussion, sleep deprivation and ADHD subjects has been published over the last 10 years in leading neurological and neurosurgical journals. RightEye Sensorimotor allows eye care professionals to quickly and objectively identify and address previously unknown binocular vision issues and oculomotor dysfunction in every patient. Built on the FDA-cleared RightEye Vision System™ and backed by over 30 years of science, RightEye Sensorimotor is designed to help diagnose and improve patient care.

tbi3
Positioned for Success

CORPORATE LEADERSHIP TEAM

Chief Executive Officer

Ash Taha MD

Dr. Ash Taha MD has trained as a surgical resident at one of the nation’s most prestigious burn centers, Maricopa Medical Center in Phoenix, Arizona and completed his training at the Department of Orthopedics and Rehabilitation at the State University of New York, Brooklyn (Downstate). After completing his Pain Fellowship, he left private practice to become the CEO/President of SpineLOOP™, which he co-founded in 2015. SpineLOOP™ is the pioneer of minimally invasive spine surgery solutions using SpineLOOP’s proprietary LOOP technology. He established and nurtured Spineloop from seed to present day, preparing the device for first in man studies. He assembled key thought leaders and industry experts as part of the Executive Team and Scientific Advisory Board Committee to further the success of the company. Dr. Taha has filed over 20 patents covering the fields of robotics, stimulators, pain pumps, spine surgery, medical cannabis, and cardiovascular medicine.